Used primarily in cancer research, particularly as an inhibitor of tyrosine kinases involved in tumor growth and angiogenesis. It targets receptors such as FGFR, VEGFR, and PDGFR, making it valuable in studies focused on blocking signaling pathways that promote cancer cell proliferation and survival. Commonly applied in preclinical studies to evaluate its efficacy against various solid tumors, including renal cell carcinoma and hepatocellular carcinoma. Also utilized in combination therapies to assess synergistic effects with other anticancer agents. Its lactate salt form improves solubility, aiding in formulation for in vitro and in vivo experiments.